Across TCGA pan-cancer cohorts, RNA5SP183 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNA5SP183 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNA5SP183 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP183 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, ESCA, and SKCM are the cancer types where RNA5SP183 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.350	0.647	.003	72	view →
ESCA	OS	Tertile	III,IV	0.710	0.373	.045	6	view →
SKCM	DFS	Tertile	All	0.614	0.739	.022	6	view →
THCA	DFS	Tertile	II,III,IV	0.768	0.929	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNA5SP183 tumor-vs-normal RNA expression · all RNA5SP183 data types